CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

Clinical trial NCT06326463 · RECRUITING

Trial details

NCT number: NCT06326463
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy ALL, Childhood AML, Childhood Lymphoma MDS

Start date: 2024-10-16
Primary completion: 2030-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.